Additional information
| Active substance | Sorafenib |
|---|---|
| Water Retention | Minimal |
| Hepatotoxicity | Yes, can cause liver injury |
| Lab Test | Liver function tests are recommended |
| Strength | 200mg |
| Also known as | BAY 43-9006 |
| Blood pressure | Can cause hypertension |
| Trade name | Nexavar |
| Storage conditions | Store at room temperature, protect from moisture |
| Chemical name | 4-(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N-methylpyridine-2-carboxamide |
| Formula | C21H16ClF3N4O3 |
| Substance class | Kinase inhibitor |
| Main action | Antineoplastic agent |
| Half-life | Approximately 25 to 48 hours |
| Dosage (medical) | Typically 400 mg twice daily |
| Dosage (sports) | Not applicable |
| Effects | Inhibits tumor cell proliferation and angiogenesis |
| Side effects | Diarrhea, rash, fatigue, hypertension, hand-foot skin reactions |
| Use in sports | None |
| Manufacturer | Cipla Ltd. |
| Packing | 30 tabs/bottle |
Avory Pharma Oxymethelone 10mg 100 Kapseln
Prograf 1mg Astellas Pharma
Tavanic 500 mg Sanofi
Euthyrox 50 mcg MERC
FACTIVE 320 mg Abdi Ibragim
Rovamycine 3.000.000 iu Eczacibasi
Fostimon (Merional) 150 IU HMG IBSA
Norvacs 5 mg Pfizer
Zimaks 400 Bilim 

Reviews
There are no reviews yet.